Teva Canada recalls some Pregabalin capsules over sertraline contamination concerns

Teva Canada has issued a recall for certain batches of its Teva-Pregabalin 150 mg capsules due to potential contamination with sertraline, an antidepressant not intended for this medication. Routine testing revealed the issue, prompting the recall to ensure patient safety. This move underscores the importance of stringent quality control in pharmaceutical manufacturing. The presence of an unauthorized drug could have serious health implications, highlighting the need for vigilance in drug production and distribution.